These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2999651)

  • 21. Regulatory aspects of nigrostriatal dopaminergic neurons.
    Miu P; Karoum F; Toffano G; Commissiong JW
    Exp Brain Res; 1992; 91(3):489-95. PubMed ID: 1483521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
    Wood PL; Nair NP; Bozarth M
    Neurosci Lett; 1982 Oct; 32(3):291-4. PubMed ID: 6294566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of increases in impulse flow.
    Tepper JM; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):309-16. PubMed ID: 6089959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No mediolateral differences in striatal autoreceptor-mediated modulation of dopamine release: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1990 Feb; 109(1-2):123-7. PubMed ID: 1969128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrical stimulation of the nigrostriatal pathway after HA-966 block of triatal dopamine release.
    Van Valkenburg CF; Noach EL
    Eur J Pharmacol; 1978 Mar; 48(2):171-7. PubMed ID: 639847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: anatomical, electrochemical and pharmacological characterisation.
    Stamford JA; Kruk ZL; Millar J
    Brain Res; 1988 Jun; 454(1-2):282-8. PubMed ID: 3261616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of electrical stimulation of the nigrostriatal pathway of the rat on dopamine metabolism.
    Korf J; Grasdijk L; Westerink BH
    J Neurochem; 1976 Mar; 26(3):579-84. PubMed ID: 1262880
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro and in vivo characterization of the properties of a multifiber carbon electrode allowing long-term electrochemical detection of dopamine in freely moving animals.
    el Ganouni S; Forni C; Nieoullon A
    Brain Res; 1987 Feb; 404(1-2):239-56. PubMed ID: 3494483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage.
    Stachowiak MK; Keller RW; Stricker EM; Zigmond MJ
    J Neurosci; 1987 Jun; 7(6):1648-54. PubMed ID: 3110381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3]Pirenzepine binding in rat corpus striatum decreases after hemitransection of the nigro-striatal pathway.
    Pittaluga A; Versace P; Marchi M; Raiteri M
    Fundam Clin Pharmacol; 1987; 1(5):317-25. PubMed ID: 3443424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat.
    Clark D; Chiodo LA
    Synapse; 1988; 2(5):474-85. PubMed ID: 2903568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Brain Res; 1990 May; 515(1-2):173-80. PubMed ID: 2357555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.